Free Trial

Nanobiotix (NBTX) Stock Forecast & Price Target

Nanobiotix logo
$41.86 +7.09 (+20.39%)
Closing price 04:00 PM Eastern
Extended Trading
$41.88 +0.02 (+0.04%)
As of 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nanobiotix - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
1
Hold
1
Buy
4

Based on 6 Wall Street analysts who have issued ratings for Nanobiotix in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 1 has given a sell rating, 1 has given a hold rating, and 4 have given a buy rating for NBTX.

Consensus Price Target

$26.67
-36.30% Downside
According to the 6 analysts' twelve-month price targets for Nanobiotix, the average price target is $26.67. The highest price target for NBTX is $36.00, while the lowest price target for NBTX is $14.00. The average price target represents a forecasted downside of -36.30% from the current price of $41.86.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for NBTX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nanobiotix and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NBTX Analyst Ratings Over Time

TypeCurrent Forecast
5/6/25 to 5/6/26
1 Month Ago
4/6/25 to 4/6/26
3 Months Ago
2/5/25 to 2/5/26
1 Year Ago
5/6/24 to 5/6/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$26.67$25.00$11.00$8.00
Forecasted Upside-36.30% Downside-23.69% Downside-47.69% Downside125.67% Upside
Consensus RatingModerate BuyModerate BuyHoldModerate Buy

NBTX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NBTX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Nanobiotix Stock vs. The Competition

TypeNanobiotixMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.30
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside-36.30% Downside913.16% Upside14.01% Upside
News Sentiment Rating
Positive News

See Recent NBTX News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/1/2026
UBS Group AG logo
UBS Group
4 of 5 stars
Colin Bristow
Colin Bristow
Not Rated
Boost TargetNeutral$3.50 ➝ $30.00-13.34%
4/21/2026 Reiterated RatingSell (D-)
4/2/2026
Guggenheim logo
Guggenheim
5 of 5 stars
Michael Schmidt
Michael Schmidt
5 of 5 stars
Boost TargetBuy$26.00 ➝ $36.00+16.46%
3/12/2026 Reiterated RatingBuy
11/25/2025Reiterated RatingOutperform
11/4/2025 Reiterated RatingBuy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 08:06 PM ET.


NBTX Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Nanobiotix is $26.67, with a high forecast of $36.00 and a low forecast of $14.00.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nanobiotix in the last year. There is currently 1 sell rating, 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NBTX shares.

According to analysts, Nanobiotix's stock has a predicted downside of -36.30% based on their 12-month stock forecasts.

Nanobiotix has been rated by research analysts at Guggenheim, TD Cowen, UBS Group, and Weiss Ratings in the past 90 days.

Analysts like Nanobiotix more than other "medical" companies. The consensus rating for Nanobiotix is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how NBTX compares to other companies.


This page (NASDAQ:NBTX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners